NYSE · AMWL
American Well Corporation
$14.98+$0.86 (+6.09%)
American Well Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.19% below the high.
Loading market information…
NASDAQ · INCR · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
InterCure Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow InterCure Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $27.73M-72.63% vs estimate |
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$14.98+$0.86 (+6.09%)
American Well Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.19% below the high.
$3.90+$0.25 (+6.85%)
CAMP4 Therapeutics Corporation’s quoted price sits in the lower half of its reported 52-week range, 49.68% below the high.
$4.76-$0.03 (-0.52%)
Edap Tms S.a.’s quoted price sits in the upper half of its reported 52-week range, 5.84% below the high.
$23.50$0.00 (0.0%)
Assertio Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$1.17$0.00 (0.0%)
Cardiol Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$2.65$0.00 (0.0%)
Repare Therapeutics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.38% below the high.
$3.81+$0.05 (+1.33%)
Unicycive Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 56.41% below the high.
$2.00+$0.04 (+2.04%)
Fortress Biotech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.85% below the high.
